Roivant Sciences (ROIV) Gross Margin (2020 - 2026)
Roivant Sciences (ROIV) reported Gross Margin of 80.31% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 12.60 percentage points from 92.90% a year earlier and down 7.00 percentage points from the prior quarter.
Roivant Sciences (ROIV) Gross Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Roivant Sciences' Gross Margin came in at 81.21%, down 15.12 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 84.44%, down 12.42 percentage points from FY2025.
- Gross Margin has a five-year change of -6.91 percentage points (FY2021 to FY2026).
- By fiscal year, Gross Margin came in at 96.86% in FY2025 (+1.75 pp), 95.11% in FY2024 (+4.73 pp), 90.38% in FY2023 (+6.59 pp) and 83.78% in FY2022 (-7.57 pp).
- Five-year quarterly Gross Margin spans a low of 54.38% in fiscal Q2 2022 and a high of 98.73% in fiscal Q3 2024.
- Year over year, Gross Margin has now declined in each of the last seven quarters, with an average year-over-year change of -7.78 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was fiscal Q2 2024 (a gain of 22.94 percentage points); the low point was fiscal Q3 2026 (a drop of 32.15 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 87.30% (Q4 2026), 64.98% (Q3 2026) and 92.93% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 80.31% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.31% |
| Mar 31, 2026 | 87.30% |
| Dec 31, 2025 | 64.98% |
| Sep 30, 2025 | 92.93% |
| Jun 30, 2025 | 92.90% |
| Mar 31, 2025 | 97.29% |
| Dec 31, 2024 | 97.13% |
| Sep 30, 2024 | 94.77% |
| Jun 30, 2024 | 97.33% |
| Mar 31, 2024 | 97.83% |
| Dec 31, 2023 | 98.73% |
| Sep 30, 2023 | 93.89% |
| Jun 30, 2023 | 80.51% |
| Dec 31, 2022 | 78.97% |
| Sep 30, 2022 | 70.95% |
| Jun 30, 2022 | 60.04% |
| Mar 31, 2022 | 95.02% |
| Dec 31, 2021 | 94.31% |
| Sep 30, 2021 | 54.38% |
| Jun 30, 2021 | 90.41% |
Roivant Sciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();